Back to search

Article

Development and Validation of an Individualized Immune Prognostic Signature in HNSCC

2022-09-13

Abstract excerpt

Head and neck cancer is the seventh most common type of cancer worldwide, and the development of immunotherapy is conducive to the preservation of function and the improvement of prognosis. Based on immune gene database ImmPort and InnateDB, we investigated prognostic value of 546 head and necks squamous cell carcinoma samples from The Cancer Genome Atlas. We intersected of the two databases, selected specific mod...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
68fcbae1-a8a4-58d3-a77a-5fa3474680fd
DOI
10.21203/rs.3.rs-2007096/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Development and Validation of an Individualized Immune Prognostic Signature in HNSCCDOI 10.21203/rs.3.rs-2007096/v1
Select a neighboring publication to make it the new centre.